| The effect of perioperative ketamine and esketamine administration on postoperative nausea and vomiting in patients undergoing general anesthesia: a systematic review and meta-analysis |
Kwon Hui Seo1 
, Shu Chung Choi1
, Jueun Kwak1
, Na Jin Kim2
|
1Department of Anesthesiology and Pain Medicine, Yeouido St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea
2Medical Library, College of Medicine, The Catholic University of Korea, Seoul, Korea |
Corresponding author:
Kwon Hui Seo, Tel: +82-2-3779-1268, Fax: +82-2-783-0368,
Email: kwonhui@catholic.ac.kr
|
|
Received: 29 December 2024 • Revised: 6 May 2025 • Accepted: 8 May 2025 |
|
|
|
| Abstract |
Background
The effects of perioperative ketamine and esketamine on postoperative nausea and vomiting (PONV) remain unclear. This study aimed to clarify their impact on PONV and related adverse events.
Methods
We performed a meta-analysis of randomized controlled trials and observational studies comparing ketamine or esketamine with control agents. The primary outcome was a pooled analysis of PONV and nausea-only data. PONV, postoperative nausea (PON), and postoperative vomiting (POV) were also analyzed separately. Subgroup analyses were conducted by comparator type (placebo, opioid, or non-opioid) and dose categories. Meta-regression was used to assess dose-response relationships.
Results
Fifty-five studies (n = 6676) were included. Ketamine and esketamine did not significantly reduce the incidence of pooled PONV risk (risk ratio [RR]: 0.95, 95% CI [0.87–1.04], P = 0.274). No benefit was found versus placebo. Compared with opioids, PONV was reduced (RR: 0.50, 95% CI [0.32–0.77], P = 0.002), but not in the pooled analysis (RR: 0.69, 95% CI [0.43–1.08], P = 0.107). Conversely, compared with non-opioid controls, ketamine/esketamine increased the pooled PONV risk (RR: 1.46, 95% CI [1.03–2.05], P = 0.032). No significant dose-response relationship was found. Both agents increased hallucinations (RR: 1.73, 95% CI [1.35–2.20], P = 0.0002) and drowsiness (RR: 2.18, 95% CI [1.13–4.21], P = 0.024).
Conclusions
Ketamine and esketamine did not significantly reduce PONV overall. While they showed benefits compared with opioid-based regimens, they may be less effective than non-opioid adjuvants. However, their neuropsychiatric and sedative risks warrant cautious use. |
| Key Words:
Esketamine; General anesthesia; Hallucination; Ketamine; Opioid analgesics; Postoperative nausea and vomiting |
|
PDF Links
XML Download
Full text via DOI
Download Citation
Print
